Amedisys (AMED) Competitors

Addus HomeCare (NASDAQ:ADUS) and Amedisys (NASDAQ:AMED) are both medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, earnings, valuation, community ranking, media sentiment, risk, profitability, analyst recommendations and dividends.

Does the MarketBeat Community prefer ADUS or AMED?

Amedisys received 187 more outperform votes than Addus HomeCare when rated by MarketBeat users. However, 66.90% of users gave Addus HomeCare an outperform vote while only 58.19% of users gave Amedisys an outperform vote.

Company	Underperform	Outperform
Addus HomeCare	Outperform Votes 289 66.90%	Underperform Votes 143 33.10%
Amedisys	Outperform Votes 476 58.19%	Underperform Votes 342 41.81%

Do insiders and institutionals believe in ADUS or AMED?

95.3% of Addus HomeCare shares are held by institutional investors. Comparatively, 95.7% of Amedisys shares are held by institutional investors. 4.4% of Addus HomeCare shares are held by insiders. Comparatively, 1.8% of Amedisys shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Do analysts rate ADUS or AMED?

Addus HomeCare presently has a consensus target price of $107.50, indicating a potential upside of 20.57%. Amedisys has a consensus target price of $103.55, indicating a potential upside of 10.14%. Given Amedisys' stronger consensus rating and higher possible upside, analysts clearly believe Addus HomeCare is more favorable than Amedisys.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Addus HomeCare	0 Sell rating(s)	0 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	3.00
Amedisys	0 Sell rating(s)	9 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.18

Which has stronger earnings & valuation, ADUS or AMED?

Amedisys has higher revenue and earnings than Addus HomeCare. Addus HomeCare is trading at a lower price-to-earnings ratio than Amedisys, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Addus HomeCare	$951.12M	1.52	$46.03M	$3.55	25.12
Amedisys	$2.22B	1.38	$118.61M	$0.07	1,343.19

Is ADUS or AMED more profitable?

Addus HomeCare has a net margin of 5.61% compared to Addus HomeCare's net margin of 0.12%. Addus HomeCare's return on equity of 13.45% beat Amedisys' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Addus HomeCare	5.61%	9.39%	6.45%
Amedisys	0.12%	13.45%	7.45%

Which has more risk & volatility, ADUS or AMED?

Addus HomeCare has a beta of 0.87, indicating that its stock price is 13% less volatile than the S&P 500. Comparatively, Amedisys has a beta of 0.96, indicating that its stock price is 4% less volatile than the S&P 500.

Does the media prefer ADUS or AMED?

In the previous week, Amedisys had 3 more articles in the media than Addus HomeCare. MarketBeat recorded 5 mentions for Amedisys and 2 mentions for Addus HomeCare. Amedisys' average media sentiment score of 1.32 beat Addus HomeCare's score of 0.37 indicating that Addus HomeCare is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Addus HomeCare	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Amedisys	0 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

Addus HomeCare and Amedisys tied by winning 9 of the 18 factors compared between the two stocks.